Fusarium spp. as a cause of lung infection in a patient living with HIV/AIDS

Authors

  • Josias Oliveira Aragão Instituto de Infectologia Emílio Ribas, - São Paulo - SP - Brasil
  • Nilton José Fernandes Cavalcante Instituto de Infectologia Emílio Ribas, - São Paulo - SP - Brasil

DOI:

https://doi.org/10.5935/Infect_evidencia/e20220714

Keywords:

Fusarium, HIV, Pneumonia, Glucocorticoids, Neutropenia, Critical Care, Case Report

Abstract

Fusarium is a genus of filamentous fungi that causes invasive disease in immunocompromised patients, especially those with hematologic cancer. AIDS immunosuppression has not been classically related to severe infection by this fungus. However, associated factors, such as prolonged neutropenia, use of corticosteroids, and T-cell deficiency, may predispose these patients to greater disease severity. This report describes a case of lung infection caused by Fusarium spp. in a patient living with HIV/AIDS after prolonged hospitalization in an intensive care unit due to multiple complications and co-infections.

References

1. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20(4):695-704.

2. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994; 28 Suppl 1:7-15.

3. Galimberti R, Torre AC, Baztán MC, Rodriguez-Chiappetta F. Emerging systemic fungal infections. Clin Dermatol. 2012; 30(6):633-50.

4. Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015; 36(5):706-14.

5. Batista BG, Chaves MA, Reginatto P, Saraiva OJ, Fuentefria AM. Human fusariosis: An emerging infection that is difficult to treat. Rev Soc Bras Med Trop. 2020; 53:e20200013. https://doi.org/10.1590/0037-8682-0013-2020

6. Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine (Baltimore). 2013; 92(6):305-16.

7. Marom EM, Holmes AM, Bruzzi JF, Truong MT, O’Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008; 190(6):1605-9.

8. Guarro J, Gené J. Fusarium infections. Criteria for the identification of the responsible species. Mycoses. 1992; 35(5-6):109-14.

9. Summerell, BA. Resolving Fusarium: current status of the genus. Annu Rev Phytopathol. 2019; 57:15.1–15.17

10. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020; 71(6):1367-76.

11. Giacobbe DR, Cortegiani A, Karaiskos I, Mercier T, Tejada S, Peghin M, et al: The Fundicu Investigators. Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis. J Fungi (Basel). 2021; 7(3):176. https://doi.org/10.3390/jof7030176.

12. Eljaschewitsch J, Sandfort J, Tintelnot K, Horbach I, Ruf B. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses. 1996; 39(3-4):115-9.

13. Glasgow BJ, Engstrom RE Jr, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol. 1996; 114(7):873-7.

14. Paugam A, Baixench MT, Frank N, Bossi P, de Pinieux G, Tourte-Schaefer C, et al. Localized oral Fusarium infection in an AIDS patient with malignant lymphoma. J Infect. 1999; 39(2):153-4.

15. Guarro J, Nucci M, Akiti T, Gené J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol. 2000; 38(9):3460-2.

16. Tascini C, Ferranti S, Leonildi A, Menichetti F. Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection. J Chemother. 2006; 18(2):227-8.

17. Esnakula AK, Summers I, Naab TJ. Fatal disseminated fusarium infection in a human immunodeficiency virus positive patient. Case Rep Infect Dis. 2013;2013:379320. https://doi.org/10.1155/2013/379320

18. Kumari I, Singh SK, Chauhan RK, Kaushal SK. Disseminated cutaneous fusariosis in human immunodeficiency virus-infected patient and dramatic response with oral itraconazole. Indian J Dermatol Venereol Leprol. 2018; 84(3):362-8.

19. Medaglia AA, Marco-Hernández J, de Ossó Acuña JT, Hermida Lama E, Martínez-Rebollar M, Caballero M, et al. Fusarium keratoplasticum infection in an HIV-infected patient. Int J STD AIDS. 2018; 29(10):1039-42.

20. Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2014; 20(6):580-5.

21. Nucci M, Anaissie E. How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. Blood. 2014; 124(26):3858-69.

22. Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003; 98(2):315-9.

Downloads

Additional Files

Published

2022-09-26

How to Cite

Aragão, J. O., & Cavalcante, N. J. F. (2022). Fusarium spp. as a cause of lung infection in a patient living with HIV/AIDS. Infections in Evidence, 1, e20220714. https://doi.org/10.5935/Infect_evidencia/e20220714

Issue

Vol. 1 (2022)

Section

Case Reports

License

Copyright (c) 2022 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.